but the new studies — two published tuesday in jama internal medicine and one wednesday in the new england journal of medicine — found that tocilizumab did not reduce the death rates of covid-19 patients.
but the new studies — two published tuesday in jama internal medicine and one wednesday in the new england journal of medicine — found that tocilizumab did not reduce the death rates of covid-19 patients.